{
    "nctId": "NCT01240213",
    "briefTitle": "Vitamin D, Diet and Activity Study",
    "officialTitle": "Vitamin D, Weight Loss, and Breast Cancer Biomarkers",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Obesity, Hypovitaminosis D",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "N/A",
    "enrollmentCount": 218,
    "primaryOutcomeMeasure": "Compare the effects of a 1-year one year Vitamin D supplementation vs placebo, on weight loss in postmenopausal women following a weight loss diet and exercise program.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age 50-75 years\n* Postmenopausal (no periods for past 12 months)\n* Screening serum vitamin D (25(OH)D) between 10 and 32 ng/mL (\"insufficient\")\n* No menopausal HRT use of any type including vaginal X 6 months and willing to avoid use for study duration\n* BMI \\> 25.0 kg/m2 (\\> 23.0 for Asians)\n* Physically able to undertake a calorie reduction and exercise program\n* Able to come for clinic visits, classes, and measurements, fill out questionnaires and logs in English\n* Gives informed consent, agrees to be randomly assigned\n\nExclusion Criteria:\n\n* Currently using more that 400 IU vitamin D from supplemental sources\n* Screening vitamin D level \\< 10 ng/mL (will be referred to primary provider) or \\> 32 ng/mL (already sufficient)\n* Osteoporosis\n* Renal disease, history of kidney stones\n* Any contra-indications to taking vitamin D 2000 IU/day\n* Plans to leave the study area within the follow-up period\n* Plans to join another organized weight loss program or take appetite suppressant medication during the study period\n* History of bariatric surgery\n* Current use of medications likely to interfere with adherence to interventions or study outcomes\n* Current smoker\n* Personal history of invasive or in situ breast cancer\n* Personal history of invasive cancer other than breast: except for non- melanoma skin cancer which would be eligible\n* Diabetes mellitus\n* Abnormalities on screening physical that contraindicate participation\n* Severe congestive heart failure per NYHA criteria 3 \\& 4\n* Contraindications for entry into a research exercise program: recent (within 6 months) myocardial infarction, pulmonary edema, myocarditis, pericarditis, unstable angina, pulmonary embolism, deep vein thrombosis, uncontrolled hypertension (systolic \\> 200, diastolic \\> 100), orthostatic hypotension, moderate/severe aortic stenosis, uncontrolled arrythmia, uncontrolled congestive heart failure, left bundle branch block, history of cardiac arrest or stroke\n* Alcohol or drug abuse, significant mental illness (as assessed by study staff impression)\n* For the RPFNA/adipose tissue substudy: bilateral breast cancer, bilateral mastectomy, unable or unwilling to stop aspirin or NSAIDs for 1 week before and after the procedure, allergy to anesthetics or local anesthetics.",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}